These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34491673)

  • 21. Minocycline-induced hyperpigmentation in leprosy.
    Fleming CJ; Hunt MJ; Salisbury EL; McCarthy SW; Barnetson RS
    Br J Dermatol; 1996 Apr; 134(4):784-7. PubMed ID: 8733393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immuno-allergic accidents with rifamipcin].
    Flageul B; Wagner L; Cottenot F
    Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total agranulocytosis caused by dapsone therapy for tuberculoid leprosy--an unappreciated serious side effect of anti-leprosy treatment with clinical implications.
    Satarasinghe RL; Jayawardana MA; De Silva GV; Murugathas S; Riyaaz AA; Wickrmasingha UD; Wijesinghe R
    Drug Metabol Drug Interact; 2009; 24(2-4):325-9. PubMed ID: 20408505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ominous sign of a disfiguring disease. Leprosy (Hansen's disease).
    Winter CA; Hsu S
    Postgrad Med; 2000 May; 107(5):87-9. PubMed ID: 10844944
    [No Abstract]   [Full Text] [Related]  

  • 25. Photosensitisation induced by clofazimine in a cat.
    Bennett Sl
    Aust Vet J; 2007 Sep; 85(9):375-80. PubMed ID: 17760943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An unusual cause of small-intestine mucosal pigmentation.
    Raftopoulos SC; Fermoyle S
    Gastrointest Endosc; 2011 Jun; 73(6):1285-6. PubMed ID: 21354567
    [No Abstract]   [Full Text] [Related]  

  • 27. Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
    Sehgal VN; Kumar S; Jain S; Bhattacharya SN
    J Dermatol; 1998 Jan; 25(1):63-5. PubMed ID: 9519615
    [No Abstract]   [Full Text] [Related]  

  • 28. Relapse in a borderline-tuberculoid case of leprosy 5 years after the release from rifampicin monotherapy.
    Shetty VP; Antia NH
    Lepr Rev; 1997 Jun; 68(2):162-6. PubMed ID: 9217356
    [No Abstract]   [Full Text] [Related]  

  • 29. Dermoscopy of borderline tuberculoid leprosy.
    Ankad BS; Sakhare PS
    Int J Dermatol; 2018 Jan; 57(1):74-76. PubMed ID: 28833001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unusual fixed drug eruption due to rifampicin.
    Jaiswal AK; Vaishampayan SS; Verma R; Varada K
    Lepr Rev; 2000 Jun; 71(2):217-8. PubMed ID: 10920617
    [No Abstract]   [Full Text] [Related]  

  • 31. Reaction in borderline tuberculoid leprosy presenting with multiple subcutaneous nodules.
    Jayakumar J; Aschhoff M; Gomathi A
    Indian J Lepr; 1993; 65(2):239-42. PubMed ID: 8345240
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of rifampin and clofazimine ointments in the treatment of leprosy.
    Venkateswarlu B; Venkataramana D; Rao AV; Prabhakar MC; Reddy BM
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):269-70. PubMed ID: 1522368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute renal failure and hepatitis induced by intermittent rifampicin therapy.
    Pandey VP; Taneja S; Talati R
    J Assoc Physicians India; 1999 Aug; 47(8):837. PubMed ID: 10778640
    [No Abstract]   [Full Text] [Related]  

  • 34. Excretion of clofazimine in human milk in leprosy patients.
    Venkatesan K; Mathur A; Girdhar A; Girdhar BK
    Lepr Rev; 1997 Sep; 68(3):242-6. PubMed ID: 9364825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bigger may not always be better: giant borderline tuberculoid leprosy lesion.
    Ghorpade A
    Lepr Rev; 2005 Jun; 76(2):182-3. PubMed ID: 16038255
    [No Abstract]   [Full Text] [Related]  

  • 36. Reactional tattoo inoculation borderline tuberculoid leprosy with oedematous tattoos.
    Ghorpade A
    Lepr Rev; 2004 Mar; 75(1):91-4. PubMed ID: 15072131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intra-abdominal, crystal-storing histiocytosis due to clofazimine in a patient with lepromatous leprosy and concurrent carcinoma of the colon.
    Pais AV; Pereira S; Garg I; Stephen J; Antony M; Inchara YK
    Lepr Rev; 2004 Jun; 75(2):171-6. PubMed ID: 15282969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clofazimine induced enteropathy--a case highlighting the importance of drug induced disease in differential diagnosis.
    Mathew BS; Pulimood AB; Prasanna CG; Ramakrishna BS; Chandy SJ
    Trop Gastroenterol; 2006; 27(2):87-8. PubMed ID: 17089619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Facial reversal reaction: a dermatological emergency.
    Marzano AV; Tosi D; Cusini M; Nunzi E; Massone C; Crosti C
    J Dermatol; 2012 Feb; 39(2):203-5. PubMed ID: 21951390
    [No Abstract]   [Full Text] [Related]  

  • 40. Dapsone-induced agranulocytosis in patients with Hansen's disease.
    Fernandes TRMO; Jesus BN; Barreto TT; Pereira AA
    An Bras Dermatol; 2017; 92(6):894-897. PubMed ID: 29364462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.